4.1 Audit and Risk Committee
The minutes of the Committee meeting of 6 June 2023 were noted and the Committee Chairperson provided a verbal report on the matters considered at the Committee meeting that took place on 14 July 2023.
The Chair advised the Board that the Committee were provided with an update from the CRO in relation to the Corporate Risk Review, and a further update will be brought to the meeting in September. The Committee noted the status of the implementation of the 50 recommendations contained in the Moody Risk Review, and focussed in particular on the 12 Critical Path recommendations identified. The Committee emphasised their support in ensuring that the Report’s recommendations are implemented across the HSE, and welcomed that progress continues to be made in implementing the recommendations and this work continues to be central to the activities of the Enterprise Risk Management Team.
The Committee were provided with an update in relation to the YTD Financial Position as at May 2023, and Health Budget Oversight Group (HBOG).
The Committee were presented with a paper on the HSE Personal Protective Equipment (PPE) Phase 2 Report & Assurance by officials from KPMG, which gave assurance that 15 recommendations had been implemented, and 2 recommendations which were due to be implemented by November 2022, had not been implemented. The Committee noted that they relate to the creation of a new National Emergency Framework which is currently under way.
The Committee considered the detail relating to Contract Approval Requests (CARs). The Chair advised the Board that in relation to the Authorisation Scheme for the Provision of Home Support Services for Older People, the Committee outlined their concerns with regard to the reduction of home help hours from 23.9mn to 22.0mn hours, and as it was not clear why the service was reducing, approval was withheld by the Committee.
The Committee also considered the detail of the remaining proposed CARs, National Contract for the provision of RT-PCR Testing of Covid (and pandemic) Specimen Samples, and Mini-Competition for Contact Management and Related Administrative Services for HSE Live and PCRS and agreed to recommend them to the Board for approval.
The Chair reported that an update was provided by the ND IA with regard to a review which was undertaken by IA to assess whether actions to resolve audit findings were implemented as reported by management and review Internal Audit’s tracking processes. The Committee highlighted their concern in relation to the number of outstanding recommendations which were very unsatisfactory and queried what was the level of oversight in the individual areas for the implementation of the recommendations. The Committee reiterated that if there is no improvement, managers will be required to attend an Audit & Risk Committee meeting to provide an explanation.
The Chair advised the Board that the Committee reviewed a paper seeking approval for the re-allocation of funding in the Capital Plan 2023. He advised the Board that the Committee had also discussed the possibility of directing some or all of the potential capital underspend towards the HSE’s revenue budget.
A summary report on transactions approved between €2m & €10m and low value/nominal CAT 3a transactions for the period of 1 April – 30 June 2023 was noted by the Committee.
The Committee considered the detail of proposed contracts, relating to Disposal of GP residence and former clinic, Inis Mór, Aran Islands, Co Galway and the Proposed lease of Surgical Hub in North Dublin, and agreed to recommend to the Board for approval.
The Committee also considered a contract that was unable to go to the Technology & Transformation Committee, Renewal of Dedalus Support and Maintenance contract, and agreed to recommend the contract to the Board for approval.
4.2 People and Culture Committee
The minutes of the Committee meeting of 12 May 2023 and the HR Dashboard were noted and the Committee Chairperson provided a verbal report on the matters considered at the Committee meeting that took place on 13 July 2023.
The Chair advised the Board that the Committee were presented with the Internal Communications report which included an update in relation to the development of a new staff email system, to which the Committee requested that this issue be brought to the attention of the Chair Technology and Transformation Committee.
The Committee were briefed on communications in relation to the Staff Survey, Climate Action Survey, Health Service Excellence Awards, Grad Link and Pride Celebrations, and congratulated the Internal Communications Team on receiving a special award at the PRII (Public Relations Institute of Ireland) awards ceremony in June.
The Chair advised the Board that the Committee were provided with an update on the Public Only Consultant Contract (POCC23), and the implementation of the recommendations of the interim report of the NCHD Taskforce.
The Committee were updated on the number of staff employed in the disability service, noting that the data provided demonstrated a net growth of 1843 WTE / + 10% across various categories of staff. The Chair advised the Board that that this information will be made available, with commentary, to the Department of Children, Equality, Disability, Integration and Youth. The Committee discussed the HSE percentage of staff employed who have a disability in the context of the statutory employment target of 3% for employment of persons with disabilities, and the ND HR will draft a briefing note for circulation to Committee members.
The CEO agreed to speak to the National Disability Authority with regard to the reporting criteria of the statutory employment target of 3% - 6% for employment of persons with disabilities.
The Committee received an update on the HR priorities for the 2024 Service Plan, a briefing in relation to CRR9 - Health, Wellbeing resilience and safety of staff, and were presented with the services provided by the HSE HR Workplace Health & Wellbeing Unit which include Occupational Health, National Employee Assistance Programme, National Health & Safety Function, Rehabilitation, and Organisational Health.
4.3 Planning and Performance Committee
The minutes of the Committee meeting of 23 June 2023 were noted and the Committee Chairperson provided a verbal report on the matters considered at the Committee meeting that took place on 21 July 2023.
The Chair advised that the Committee received an update on Communication items by the ND Communications particularly in relation to the NSP 2023 and disability services.
The Committee was presented with the monthly COO Report, Operational Service Report (May Data), Performance Profile (May Data), National Performance Oversight Group (NPOG) Meeting Notes (May Data), and the PMO Report – Winter/NSP 2022-23, with a focus on Scheduled Care, Urgent and Emergency Care (UEC) and Child and Adolescent Mental Health Services (CAMHS).
In relation to Scheduled Care, the Chair advised the Board that the Committee sought detail on waiting list management, particularly actions being taken to provide care for patients who have been on waiting lists for extended periods of time, and were provided with an update by the ND Acute Operations in relation to the dynamic purchasing solutions (DPS) that are being utilised as a short term solution.
In relation to UEC, the Committee were advised that the system has stabilised over the past number of months although it remains challenged by KPIs. The Committee discussed whether zero tolerance in relation to certain KPIs should be the aim and the culture shifts that may be necessary in some sites to achieve this.
The Committee noted that the Mental Health Commission (MHC) report on CAMHS was due to be published, and welcomed the confirmation that clinical leads for CAMHS and the adult mental health services had been appointed.
The Committee received updates relating to an older persons home care staffing tender process; Urgent Colonoscopy and Cancer Services; Therapy Waiting Lists; Serious Incident KPIs; Disability Services Assessment of Need, and escalation to National Directors under the Performance Accountability Framework 2023.
The Committee were presented with the draft Roadmap for Service Improvement 2023-2025 Disability Service for Children and young People (the Roadmap) and the Roadmap’s Monthly Progress Report. The Chair advised the Board that the Committee queried some of the language and tone of the Roadmap and recommended that it be amended to become more communicable for families.
The Committee discussed Corporate Risk Register 04 – Access to Care, and queried the allocation of risk controls and the clarity of the connection between the control and the risk description, and were updated in relation to the Health System Performance Assessment (HSPA) Framework for the Irish health system, and the National Service Plan 2024.
4.4 Safety and Quality Committee
The minutes of the Committee meeting of 16 June 2023 and the Quality Profile (May data) were noted. The Committee Chairperson provided a verbal report on the matters considered at the Committee meeting that took place on 14 July 2023.
The Chair advised the Board that the Committee were provided with an update in relation to the National Independent Review Panel (NIRP) Annual Report 2022-2023 and that NIRP have now completed four major reviews into serious reportable events and an independent review recommended, and are in the process of completing a further two reviews and will report back to the Committee.
The Chair briefed the Board on the monthly Chief Clinical Officer’s report which included an update with regard to MonkeyPox, the National Cervical Screening Laboratory (NCSL) project to build and equip the new laboratory, the Cervical Check and the Laboratory services tender, BreastCheck Radiology Shortages, The World Health Organisation’s International Agency for Research on Cancer (IARC), Radiology Diagnostics Review Imaging capacity, National Womens and Infants Health Programme (NWIHP) OEST programme, Our Ladys Hospital Navan (OLHN), Quality Profile Metric, “Urgent and Emergency Care – people over 75 years and older”, Sodium Valproate, Anti-Microbial Resistance and Infection Control (AMRIC) – Carbapenemase-producing Enterobacterales (CPE), and Genetics and Genomics.
The Committee received an update in relation to Corporate Risk Register 018 - Assisted Decision-Making Capacity Legislative Changes and the commencement of the Assisted Decision-Making (Capacity)(Amendment) Act 2022 in April 2023 and its evolving impact on both service users and their families and HSE services.
The Chair advised the Board that the Committee heard directly from patient representatives from Patients for Patient Safety Ireland (PFPSI) and were updated on the ‘Know, Check, Ask’ information campaign as well as iSIMPATHY (implementing Stimulating Innovation in the Management of Polypharmacy and Adherence Through the Years).
The Committee were updated on the Mental Health Commission’s (MHC) Annual Report 2022 and advised the Board that Mental Health has developed a detailed action plan in response to the MHC findings which is due to be submitted on 31 July 2023.
A discussion then took place in relation to Our Lady’s Hospital Navan (OLHN), and the CEO advised that there has been no further update since the June Board meeting.
4.5 Technology & Transformation Committee
The Chair of the Technology & Transformation Committee advised the Board that there was no meeting held in July 2023. The next meeting will be held in September which will include a Committee meeting and workshop to consider the PwC analysis of the status of recommendations contained in the PIR Report, to which Board members are welcome to attend.
The Committee were updated in relation to the recruitment process for the positions of the Chief Technology & Transformation Officer (CTTO) and the Chief Information Security Officer (CISO).